🇺🇸 Candesartan/HCT in United States

110 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 18 reports (16.36%)
  2. Hypotension — 14 reports (12.73%)
  3. Drug Interaction — 12 reports (10.91%)
  4. Nausea — 12 reports (10.91%)
  5. Off Label Use — 12 reports (10.91%)
  6. Hyponatraemia — 9 reports (8.18%)
  7. Vomiting — 9 reports (8.18%)
  8. Dizziness — 8 reports (7.27%)
  9. Fatigue — 8 reports (7.27%)
  10. Inflammation — 8 reports (7.27%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Candesartan/HCT approved in United States?

Candesartan/HCT does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Candesartan/HCT in United States?

Population Health Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.